Si Ge, Zhiqiang Zeng, Lei Zheng, Jiakai Ma, Deyu Wang, Yuan Ren
{"title":"Comparison of Perioperative Outcomes Between da Vinci XI and da Vinci SI/SP Robotic Radical Prostatectomies: A Meta-Analysis of Comparative Studies.","authors":"Si Ge, Zhiqiang Zeng, Lei Zheng, Jiakai Ma, Deyu Wang, Yuan Ren","doi":"10.1245/s10434-025-18498-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to compare perioperative outcomes between da Vinci XI and da Vinci SI or SP robotic radical prostatectomies.</p><p><strong>Methods: </strong>The study systematically searched four databases: Embase, PubMed, Cochrane Library, and Web of Science. The search time ranged from database creation to July 2025. Statistical analysis was performed using Stata17. Effect denoted a continuous variable, whereas OR/RR denoted a binary variable, and the 95 % confidence interval (CI) was calculated.</p><p><strong>Results: </strong>The seven included studies involved 2297 patients undergoing robotic radical prostatectomy. Compared with SP, XI had a longer hospital stay (effect, 0.91; 95 % CI 0.04-1.77; P < 0.05). Compared with SI, XI had a lower positive margin rate (odds ratio, 0.74; 95 % CI 0.57-0.97; P < 0.05). Operation time, estimated blood loss, overall complications, and major complications did not differ among XI, SI, and SP.</p><p><strong>Conclusion: </strong>Compared with SP, XI's hospital stay appeared to be longer. Compared with SI, XI seemed to have a lower positive surgical margin. However, more research is needed to determine differences in oncology outcomes and cost-effectiveness among several robotic surgical platforms.</p>","PeriodicalId":8229,"journal":{"name":"Annals of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1245/s10434-025-18498-w","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study aimed to compare perioperative outcomes between da Vinci XI and da Vinci SI or SP robotic radical prostatectomies.
Methods: The study systematically searched four databases: Embase, PubMed, Cochrane Library, and Web of Science. The search time ranged from database creation to July 2025. Statistical analysis was performed using Stata17. Effect denoted a continuous variable, whereas OR/RR denoted a binary variable, and the 95 % confidence interval (CI) was calculated.
Results: The seven included studies involved 2297 patients undergoing robotic radical prostatectomy. Compared with SP, XI had a longer hospital stay (effect, 0.91; 95 % CI 0.04-1.77; P < 0.05). Compared with SI, XI had a lower positive margin rate (odds ratio, 0.74; 95 % CI 0.57-0.97; P < 0.05). Operation time, estimated blood loss, overall complications, and major complications did not differ among XI, SI, and SP.
Conclusion: Compared with SP, XI's hospital stay appeared to be longer. Compared with SI, XI seemed to have a lower positive surgical margin. However, more research is needed to determine differences in oncology outcomes and cost-effectiveness among several robotic surgical platforms.
背景:本研究旨在比较达芬奇XI和达芬奇SI或SP机器人根治性前列腺切除术的围手术期结果。方法:系统检索Embase、PubMed、Cochrane Library和Web of Science四个数据库。搜索时间范围从数据库创建到2025年7月。使用Stata17进行统计分析。Effect表示连续变量,OR/RR表示二元变量,并计算95%置信区间(CI)。结果:纳入的7项研究涉及2297例接受机器人根治性前列腺切除术的患者。与SP相比,XI的住院时间更长(效应值0.91;95% CI 0.04-1.77; P < 0.05)。与SI相比,XI的阳性边缘率较低(优势比0.74;95% CI 0.57-0.97; P < 0.05)。手术时间、估计出血量、总并发症和主要并发症在XI、SI和SP之间没有差异。结论:与SP相比,XI的住院时间更长。与SI相比,XI似乎有更低的阳性手术切缘。然而,需要更多的研究来确定几种机器人手术平台在肿瘤预后和成本效益方面的差异。
期刊介绍:
The Annals of Surgical Oncology is the official journal of The Society of Surgical Oncology and is published for the Society by Springer. The Annals publishes original and educational manuscripts about oncology for surgeons from all specialities in academic and community settings.